Neola Medical recently announced that the market preparations before the launch of the lung monitoring device Neola™ were initiated. The device is developed for continuous monitoring of the lungs of preterm born infants. One of the important activities this...
This is a translation of the Swedish press release published 2023-02-01 Neola Medical AB (publ) initiates market preparations before the launch of its medical device, Neola™ for continuous monitoring of the lungs of preterm born babies. The first action is a...
Meetings with investors and potential investors are an important part of the Company’s work to strengthen an international network. One part of this is conducting company presentations and attend various conferences, both Swedish and international. Recently, CEO Hanna...
This is a translation of the Swedish press release published 2023-01-24 Neola Medical AB (publ) announces today that the company’s trademark, Neola®, has been registered in China for class 10 (Medical device) and class 42 (Science and technology services, R&D...
On the 9th–12th of January, J.P. Morgan Healthcare Conference 2023 was arranged in San Francisco, U.S. Neola Medical’s CEO Hanna Sjöström attended the conference and took part in presentations, discussions, and conversations. In connection to the event, CEO Hanna...
This is a translation of the Swedish press release published 2023-01-02 Neola Medical AB (publ) will attend the events related to investor conference J.P. Morgan Healthcare Conference in San Francisco in January 2023. CEO Hanna Sjöström will also present the company...
